Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
Kisner, Tuelay; Burst, Volker; Teschner, Sven; Benzing, Thomas; Kurschat, Christine E.
Nephron Clin Pract
; 120(2): c79-85, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22286071
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.
Minimal-change-Glomerulonephritis und fokal-segmentale Glomerulosklerose.
Nephrotic syndrome among children in Kano: a clinicopathological study.
Ofatumumab for the treatment of childhood nephrotic syndrome.
MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: preliminary results.
Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.
Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.
Unusual Cause and Presentation of Collapsing Focal Segmental Glomerulosclerosis.
The incidence of the nephrotic syndrome in childhood in Germany.
Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.